With several long-acting HIV treatments in the works, the newest drugs emphasize convenience
As people live for decades with HIV, drugmakers respond with drugs that can be taken every few weeks
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
May 13, 2019 Cover
Volume 97, Issue 19
As people live for decades with HIV, drugmakers respond with drugs that can be taken every few weeks
Cover image:A pair of hands holding pills and a syringe.
Credit: Will Ludwig/C&EN/Shutterstock
As people live for decades with HIV, drugmakers respond with drugs that can be taken every few weeks
Incremental gains in the number of women in chemistry faculty can’t outpace the growing number who choose other careers
Russian-born scientist revolutionized chemistry by helping launch heterogeneous catalysis more than a century ago. Today, hardly anyone knows his name
Jen Heemstra on how to turn our negative thoughts into positive actions
The start-up, cofounded by Cigall Kadoch, is drugging a molecular machine called BAF, part of the chromatin regulatory system
Head of NanoBio Lab aims to move inexpensive medical diagnostics from the lab bench to the market
Restrictions placed on firefighting foam with PFOA, PFOS, or both